FI119869B - Lääkkeen elektrokuljetusvapautukseen tarkoitettu kontrollimembraani - Google Patents

Lääkkeen elektrokuljetusvapautukseen tarkoitettu kontrollimembraani Download PDF

Info

Publication number
FI119869B
FI119869B FI911589A FI911589A FI119869B FI 119869 B FI119869 B FI 119869B FI 911589 A FI911589 A FI 911589A FI 911589 A FI911589 A FI 911589A FI 119869 B FI119869 B FI 119869B
Authority
FI
Finland
Prior art keywords
membrane
body surface
substance
electrode
agent
Prior art date
Application number
FI911589A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI911589A0 (fi
Inventor
J Richard Gyory
Felix Theeuwes
Ronald P Haak
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of FI911589A0 publication Critical patent/FI911589A0/fi
Application granted granted Critical
Publication of FI119869B publication Critical patent/FI119869B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0444—Membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Electrotherapy Devices (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Pyridine Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Paper (AREA)
  • Decoration By Transfer Pictures (AREA)
  • Feeding, Discharge, Calcimining, Fusing, And Gas-Generation Devices (AREA)
FI911589A 1988-10-03 1991-04-02 Lääkkeen elektrokuljetusvapautukseen tarkoitettu kontrollimembraani FI119869B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25240288 1988-10-03
US07/252,402 US5080646A (en) 1988-10-03 1988-10-03 Membrane for electrotransport transdermal drug delivery
PCT/US1989/004318 WO1990003825A1 (en) 1988-10-03 1989-10-02 Control membrane for electrotransport drug delivery
US8904318 1989-10-02

Publications (2)

Publication Number Publication Date
FI911589A0 FI911589A0 (fi) 1991-04-02
FI119869B true FI119869B (fi) 2009-04-30

Family

ID=22955863

Family Applications (1)

Application Number Title Priority Date Filing Date
FI911589A FI119869B (fi) 1988-10-03 1991-04-02 Lääkkeen elektrokuljetusvapautukseen tarkoitettu kontrollimembraani

Country Status (14)

Country Link
US (3) US5080646A (de)
EP (2) EP0931564B1 (de)
JP (2) JP2918262B2 (de)
KR (1) KR960014099B1 (de)
AT (2) ATE234130T1 (de)
AU (2) AU627786B2 (de)
CA (2) CA1337300C (de)
DE (2) DE68929458T2 (de)
DK (2) DK175622B1 (de)
FI (1) FI119869B (de)
NO (1) NO318115B1 (de)
NZ (1) NZ230772A (de)
PT (1) PT91890B (de)
WO (1) WO1990003825A1 (de)

Families Citing this family (295)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250022A (en) * 1990-09-25 1993-10-05 Rutgers, The State University Of New Jersey Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5549924A (en) * 1987-07-17 1996-08-27 Robin Renee Thill Shlenker Method of forming a membrane, especially a latex or polymer membrane, including a deactivating barrier and indicating layer
US5679399A (en) * 1987-07-17 1997-10-21 Bio Barrier, Inc. Method of forming a membrane, especially a latex or polymer membrane, including multiple discrete layers
US5169382A (en) * 1988-10-03 1992-12-08 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5147296A (en) * 1988-10-03 1992-09-15 Alza Corporation Membrane for electrotransport transdermal drug delivery
US4927408A (en) * 1988-10-03 1990-05-22 Alza Corporation Electrotransport transdermal system
US5496266A (en) * 1990-04-30 1996-03-05 Alza Corporation Device and method of iontophoretic drug delivery
US5240995A (en) * 1989-02-09 1993-08-31 Alza Corporation Electrotransport adhesive
US5234992A (en) * 1989-02-09 1993-08-10 Alza Corporation Electrotransport adhesive
ES2095929T3 (es) * 1989-10-23 1997-03-01 Theratech Inc Dispositivo iontoforetico que emplea un regulador del regimen.
JP2816886B2 (ja) * 1990-03-05 1998-10-27 興和株式会社 生体通電装置
GR1000433B (el) * 1990-04-24 1992-07-30 Alza Corp Συσκευη και μεθοδος ιοντοφορητικης απελευθερωσης φαρμακου.
US5147297A (en) * 1990-05-07 1992-09-15 Alza Corporation Iontophoretic delivery device
US5362308A (en) * 1990-09-25 1994-11-08 Rutgers, The State University Of New Jersey Disposable dosage unit for iontophoresis-facilitated transdermal delivery, related devices and processes
US5677360A (en) * 1991-02-13 1997-10-14 Mitsubishi Rayon Co., Ltd. Hydrophilic polymer alloy, fiber and porous membrane comprising this polymer alloy, and methods for preparing them
US5405317A (en) * 1991-05-03 1995-04-11 Alza Corporation Iontophoretic delivery device
US5402777A (en) * 1991-06-28 1995-04-04 Alza Corporation Methods and devices for facilitated non-invasive oxygen monitoring
US5356632A (en) * 1991-09-12 1994-10-18 S.I. Scientific Innovations Ltd. Transdermal drug delivery device
SE9102778D0 (sv) * 1991-09-25 1991-09-25 Siemens Elema Ab Implanterbar medicinsk anordning
US5421816A (en) * 1992-10-14 1995-06-06 Endodermic Medical Technologies Company Ultrasonic transdermal drug delivery system
CA2126487C (en) * 1993-06-23 2001-05-29 Keiichiro Okabe Iontophoresis device
US5387189A (en) * 1993-12-02 1995-02-07 Alza Corporation Electrotransport delivery device and method of making same
US5508262A (en) * 1993-12-15 1996-04-16 University Of South Florida Interleukin-1 receptor antagonist decreases severity of acute pancreatitis
AU2286995A (en) * 1994-04-08 1995-10-30 Alza Corporation Electrotransport system with ion exchange competitive ion capture
FR2719485B1 (fr) * 1994-05-06 1996-07-12 Lhd Lab Hygiene Dietetique Procédé et dispositif de mesure de la quantité d'un principe actif contenu dans un réservoir.
JP3523334B2 (ja) * 1994-07-02 2004-04-26 久光製薬株式会社 イオントフォレ−シス用プラスター構造体
US5861439A (en) * 1994-11-14 1999-01-19 Alza Corporation Method for enhanced electrotransport agent delivery
FR2726769B1 (fr) * 1994-11-16 1997-01-31 Lhd Lab Hygiene Dietetique Dispositif ionophoretique d'administration transdermique de medicaments et ensemble jetable formant partie d'un tel dispositif
US5855867A (en) * 1995-03-29 1999-01-05 The Curators Of The University Of Missouri Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
WO2000023144A1 (en) * 1995-04-23 2000-04-27 Electromagnetic Bracing Systems, Inc. Transdermal active drug delivery system and method
IL113459A (en) * 1995-04-23 2000-07-16 Electromagnetic Bracing System Electrophoretic cuff apparatus
US5853383A (en) * 1995-05-03 1998-12-29 Alza Corporation Preparation for formulations for electrotransport drug delivery
US6881208B1 (en) * 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
US6425892B2 (en) 1995-06-05 2002-07-30 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
CN1147329C (zh) * 1995-06-05 2004-04-28 阿尔萨公司 用于经皮肤电输送芬太尼和苏芬太尼的装置
US6216033B1 (en) 1996-05-22 2001-04-10 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
ZA964320B (en) * 1995-06-05 1997-01-13 Alza Corp Device for transdermal electrotransport delivery of fentanyl and sufentanil
US5747453A (en) 1995-06-06 1998-05-05 Alza Corporation Method for increasing the electrotransport flux of polypeptides
US5983130A (en) * 1995-06-07 1999-11-09 Alza Corporation Electrotransport agent delivery method and apparatus
US7572252B1 (en) 1995-06-07 2009-08-11 Alza Corporation Electrotransport agent delivery method and apparatus
US5767084A (en) * 1995-10-06 1998-06-16 The Curators Of The University Of Missouri Method of treatment for cystic fibrosis and peptides for same
CA2235036A1 (en) 1995-11-08 1997-05-15 University Of South Florida Guinea pig model for leiomyomas and atherosclerosis
ATE295157T1 (de) 1996-01-30 2005-05-15 Novagent Oy Mittel zur transdermalen verabreichung von arzneistoffen
US6333189B1 (en) 1996-06-06 2001-12-25 Alza Corporation Method of making an electrotransport device
US6718201B1 (en) * 1996-06-07 2004-04-06 Alza Corporation Electrotransport agent delivery method and apparatus
DK0914178T3 (da) * 1996-06-18 2003-04-22 Alza Corp Anordning til forøgelse af transdermal afgivelse eller prøveudtagning af et middel
EP0920345A4 (de) * 1996-06-19 2006-05-10 Vyteris Inc Iontophoretische abscheidung von zelladhäsions-inhibitoren
US5908400A (en) * 1996-06-20 1999-06-01 Hisamitsu Pharmaceutical Co., Inc. Device structure for iontophoresis
US5941843A (en) * 1996-07-12 1999-08-24 Empi, Inc. Iontophoresis electrode
US5871461A (en) * 1996-07-12 1999-02-16 Empi, Inc. Method of making an iontophoresis electrode
US5857993A (en) * 1996-07-12 1999-01-12 Empi, Inc. Process of making an iontophoresis electrode
US6350259B1 (en) 1996-09-30 2002-02-26 Vyteris, Inc. Selected drug delivery profiles using competing ions
US5906976A (en) * 1996-10-22 1999-05-25 Ramot-University Authority For Applied Research And Industrial Development, Ltd. Method and composition for treating neuronal degeneration
FR2755372B1 (fr) * 1996-11-07 1998-12-24 Elf Aquitaine Dispositif d'ionophorese comportant au moins un ensemble electrode a membrane, pour l'administration transcutanee de principes actifs a un sujet
US6246904B1 (en) 1996-12-17 2001-06-12 Alza Corporation Electrotransport drug delivery reservoirs containing inert fillers
US6650934B2 (en) 1996-12-17 2003-11-18 Alza Corp Polymeric foam reservoirs for an electrotransport delivery device
US6119036A (en) 1997-03-26 2000-09-12 The Board Of Regents Of The University Of Oklahoma Iontophoretic transdermal delivery device
US5976547A (en) * 1997-04-22 1999-11-02 Niblick Pharmaceuticals, Inc. Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery
US6004577A (en) * 1997-08-12 1999-12-21 Murdock; Thomas O. Enhanced electrotransport of therapeutic agents having polybasic anionic counter ions
US6775569B2 (en) 1997-11-05 2004-08-10 Hisamitsu Pharmaceutical Co., Inc. Electroporation device for in vivo delivery of therapeutic agents
EP1030688B1 (de) * 1997-11-12 2004-09-29 Alza Corporation Verfahren zur dermalen verabreichung von polypeptiden
JP3980140B2 (ja) * 1997-12-04 2007-09-26 村越 寧根 治療器具
US6918901B1 (en) * 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
EP1911488A3 (de) 1997-12-11 2008-12-03 Alza Corporation Vorrichtung zur Verstärkung des Flusses transdermaler Mittel
PT1037686E (pt) * 1997-12-11 2005-10-31 Alza Corp Aparelho para potenciar o fluxo de agente transdermico
KR100557261B1 (ko) 1997-12-11 2006-03-07 알자 코포레이션 경피성 작용제 유동률을 증진시키기 위한 장치
DE69806963T2 (de) * 1997-12-11 2002-11-21 Alza Corp Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses
US6163720A (en) * 1997-12-18 2000-12-19 Alza Corporation Layered rate controlling membranes for use in an electrotransport device
US6374136B1 (en) * 1997-12-22 2002-04-16 Alza Corporation Anhydrous drug reservoir for electrolytic transdermal delivery device
JP4154017B2 (ja) * 1997-12-30 2008-09-24 久光製薬株式会社 イオントフォレーシス装置および薬物ユニット
US6489306B2 (en) 1998-02-23 2002-12-03 University Of South Florida Method of intranasal gene transfer for protection against respiratory infection
US6059736A (en) * 1998-02-24 2000-05-09 Tapper; Robert Sensor controlled analysis and therapeutic delivery system
US6028102A (en) * 1998-02-24 2000-02-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Anticonvulsant drugs and pharmaceutical compositions thereof
US6338834B1 (en) 1998-04-30 2002-01-15 The Curators Of The University Of Missouri Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma
US6344443B1 (en) 1998-07-08 2002-02-05 University Of South Florida Peptide antagonists of tumor necrosis factor alpha
WO2000002561A1 (en) 1998-07-13 2000-01-20 University Of South Florida Modulation of the phospholipase a2 pathway as a therapeutic
US7002003B1 (en) 1998-07-30 2006-02-21 University Of South Florida Method for the inhibition of function of STAT transcription factors
US6780397B2 (en) 1998-09-01 2004-08-24 Curators Of The University Of Missouri Biomolecule conjugation strategy using novel water-soluble phosphine-based chelating agents
US20050171021A1 (en) * 1998-11-12 2005-08-04 Cormier Michel J. Buffered drug formulations for transdermal
US20070196490A1 (en) * 1999-01-22 2007-08-23 Powderject Research Limited Method of enhancing needleless transdermal powered drug delivery
US6638974B1 (en) 1999-04-09 2003-10-28 University Of South Florida Ascorbyl esters for the treatment of cancer
US6787318B1 (en) 1999-06-01 2004-09-07 Roskamp Research Institute, Llc Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
US7135498B1 (en) 1999-06-14 2006-11-14 Henry Ford Health System Nitric oxide donors for inducing neurogenesis
EP1233670B1 (de) * 1999-06-14 2008-09-17 Henry Ford Health System Stickstoffmonoxid-donoren zum induzieren von neurogenese
US7655423B2 (en) * 1999-06-14 2010-02-02 Henry Ford Health System Nitric oxide donors for inducing neurogenesis
US6394994B1 (en) * 1999-08-27 2002-05-28 Vyteris, Inc. Method for testing the ability of an iontophoretic reservoir-electrode to deliver a medicament
US6998232B1 (en) 1999-09-27 2006-02-14 Quark Biotech, Inc. Methods of diagnosing bladder cancer
US6462066B2 (en) 1999-12-02 2002-10-08 University Of South Florida Method and composition for treatment of ischemic neuronal reperfusion injury
ES2253278T3 (es) 1999-12-10 2006-06-01 Alza Corporation Dispositivo y procedimiento para mejorar la perforacion cutanea con microprotuberancias.
WO2002003921A2 (en) * 2000-07-11 2002-01-17 University Of South Florida Bax fragment induced tumor cell death
FR2812218B1 (fr) * 2000-07-28 2003-01-10 Eastman Kodak Co Procede pour ameliorer le fonctionnement d'une membrane d'un dispositif de nanofiltration
US6803060B2 (en) 2000-09-07 2004-10-12 Joe Reyes Composition to boost libido
CA2464228C (en) * 2000-10-27 2017-01-17 Immuno-Rx, Inc. Vaccine immunotherapy for immune suppressed patients
US6553255B1 (en) 2000-10-27 2003-04-22 Aciont Inc. Use of background electrolytes to minimize flux variability during iontophoresis
US20070031372A1 (en) * 2004-08-05 2007-02-08 Hadden John W Vaccine immunotherapy for immune suppressed patients
US20070025958A1 (en) * 2000-10-27 2007-02-01 Hadden John W Vaccine immunotherapy
US7182942B2 (en) * 2000-10-27 2007-02-27 Irx Therapeutics, Inc. Vaccine immunotherapy for immune suppressed patients
US20070154399A1 (en) * 2000-10-27 2007-07-05 Hadden John W Immunotherapy for immune suppressed patients
US20060194242A1 (en) * 2000-10-27 2006-08-31 Hadden John W Immunotherapy for immune suppressed patients
WO2002081024A1 (en) * 2001-04-04 2002-10-17 Alza Corporation Transdermal electrotransport delivery device including an antimicrobial compatible reservoir composition
US6770622B2 (en) 2001-06-08 2004-08-03 Gary A. Jarvis N-terminally truncated galectin-3 for use in treating cancer
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
CA2498591A1 (en) 2001-10-26 2003-05-01 Immuno-Rx, Inc. Immunotherapy for reversing immune suppression
US7349733B2 (en) 2001-11-02 2008-03-25 Ceramatel, Inc. Iontophoretic drug delivery systems
US7047069B2 (en) 2002-02-04 2006-05-16 Ceramatec, Inc. Iontophoretic fluid delivery device
US6775570B2 (en) 2002-02-04 2004-08-10 Ceramatec, Inc. Iontophoretic treatment device
DE10205373B4 (de) * 2002-02-09 2007-07-19 Aloys Wobben Brandschutz
CA2500713C (en) 2002-10-04 2012-07-03 Photokinetix, Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
AU2003284968A1 (en) * 2002-10-25 2004-05-13 University Of South Florida Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
US6872292B2 (en) * 2003-01-28 2005-03-29 Microlin, L.C. Voltage modulation of advanced electrochemical delivery system
US7220778B2 (en) * 2003-04-15 2007-05-22 The General Hospital Corporation Methods and devices for epithelial protection during photodynamic therapy
CN1863572A (zh) * 2003-08-04 2006-11-15 阿尔扎公司 提高药剂经皮流通量的方法和装置
WO2005021065A2 (en) * 2003-08-29 2005-03-10 New York University Indirect delivery of growth factors into the central nervous system
EP1663283B1 (de) * 2003-09-12 2012-05-23 University of Colorado Glutamin zur verwendung bei der behandlung von verletzungen
JP2007510445A (ja) * 2003-10-24 2007-04-26 アルザ・コーポレーシヨン 経皮薬剤送達促進用の前処置法及びシステム
JP2007508914A (ja) * 2003-10-24 2007-04-12 アルザ・コーポレーシヨン 経皮薬剤送達を促進するための装置及び方法
US20050106227A1 (en) * 2003-10-28 2005-05-19 Samuel Zalipsky Delivery of polymer conjugates of therapeutic peptides and proteins via coated microprojections
AU2004291040A1 (en) * 2003-11-13 2005-06-02 Alza Corporation System and method for transdermal delivery
WO2005051485A1 (en) * 2003-11-19 2005-06-09 Alza Corporation Peptidically buffered formulations for electrotransport applications and methods of making
WO2005059100A2 (en) * 2003-12-12 2005-06-30 New York University Methods and compositions relating to cystatin c
KR20070015114A (ko) * 2003-12-30 2007-02-01 신드로멕스 리미티드 3,3,14,14 테트라메틸 헥사데칸 1,16 이산의 투여 방법
JP4755113B2 (ja) 2004-01-30 2011-08-24 クアーク・ファーマスーティカルス、インコーポレイテッド 線維性状態およびその他の疾患の治療のための、オリゴリボヌクレオチドおよびその使用方法
US20050220439A1 (en) * 2004-03-19 2005-10-06 Carton Owen A Interactive multimedia system and method
MXPA06011972A (es) * 2004-04-13 2007-04-16 Johnson & Johnson Aparato y metodo para el suministro transdermico de agentes a base de fentanilo.
BRPI0509788A (pt) * 2004-05-13 2007-10-23 Alza Corp aparato e método para liberação transdérmica de agentes de hormÈnio paratireóides
CA2566759A1 (en) * 2004-05-19 2005-11-24 Alza Corporation Method and formulation for transdermal delivery of immunologically active agents
US20060030811A1 (en) * 2004-08-03 2006-02-09 Wong Patrick S Method and device for enhancing transdermal agent flux
US7741299B2 (en) 2004-08-16 2010-06-22 Quark Pharmaceuticals, Inc. Therapeutic uses of inhibitors of RTP801
TW200618830A (en) * 2004-08-10 2006-06-16 Alza Corp Micorprojection apparatus and system with low infection potential
AR050608A1 (es) * 2004-08-19 2006-11-08 Alza Corp Aparato y metodo para administracion transdermica de factores de crecimiento endotelial vascular
BRPI0516177B8 (pt) 2004-09-28 2021-05-25 Quark Biotech Inc oligorribonucleotídeos, uso dos mesmos, uso de um composto sirna eficaz para inibir 0 p53 humano e composição farmacêutica que os contém, bem como método para diminuição da expressão do gene p53
JP2006116086A (ja) * 2004-10-21 2006-05-11 Tokuyama Corp イオントフォレーシス装置用作用極構造体及びイオントフォレーシス装置
US20060095001A1 (en) * 2004-10-29 2006-05-04 Transcutaneous Technologies Inc. Electrode and iontophoresis device
WO2006055729A1 (en) * 2004-11-16 2006-05-26 Transcutaneous Technologies Inc. Iontophoretic device and method for administering immune response-enhancing agents and compositions
JP4728631B2 (ja) * 2004-11-30 2011-07-20 Ｔｔｉ・エルビュー株式会社 イオントフォレーシス装置
US7590444B2 (en) * 2004-12-09 2009-09-15 Tti Ellebeau, Inc. Iontophoresis device
KR20070090907A (ko) * 2004-12-09 2007-09-06 트랜스큐 테크놀로지스 가부시키가이샤 이온토포레시스 장치
EP1844813B1 (de) * 2005-02-03 2009-10-14 TTI ellebeau, Inc. Iontophoresegerät
JP4731931B2 (ja) * 2005-02-03 2011-07-27 Ｔｔｉ・エルビュー株式会社 イオントフォレーシス装置
US20060204562A1 (en) * 2005-02-16 2006-09-14 Cormier Michel J Microprojection arrays with improved biocompatibility
AU2006214236A1 (en) * 2005-02-16 2006-08-24 Alza Corporation Apparatus and method for transdermal delivery of erythropoetin-based agents
TW200640526A (en) * 2005-02-24 2006-12-01 Alza Corp Transdermal electrotransport drug delivery systems with reduced abuse potential
JP4793806B2 (ja) 2005-03-22 2011-10-12 Ｔｔｉ・エルビュー株式会社 イオントフォレーシス装置
JP2006296511A (ja) * 2005-04-15 2006-11-02 Transcutaneous Technologies Inc 外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ
AU2006252342A1 (en) * 2005-06-02 2006-12-07 Alza Corporation Method for terminal sterilization of transdermal delivery devices
JP2006334164A (ja) * 2005-06-02 2006-12-14 Transcutaneous Technologies Inc イオントフォレーシス装置及びその制御方法
US20060280645A1 (en) * 2005-06-02 2006-12-14 Scott Sellers Method for terminal sterilization of transdermal delivery devices
JP2006346368A (ja) * 2005-06-20 2006-12-28 Transcutaneous Technologies Inc イオントフォレーシス装置及びその製造方法
JP2007000342A (ja) * 2005-06-23 2007-01-11 Transcutaneous Technologies Inc 複数薬剤の投与量および投与時期を制御するイオントフォレーシス装置
JPWO2007010900A1 (ja) * 2005-07-15 2009-01-29 Ｔｔｉ・エルビュー株式会社 貼付位置表示機能付き経皮吸収用パッチ及びイオントフォレーシス装置
KR100719095B1 (ko) * 2005-07-29 2007-05-17 성균관대학교산학협력단 연료 확산속도 제어물질층을 포함하여 메탄올 크로스오버현상을 억제시킨 직접 메탄올 연료전지
US8386030B2 (en) * 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US8295922B2 (en) 2005-08-08 2012-10-23 Tti Ellebeau, Inc. Iontophoresis device
US20070088332A1 (en) * 2005-08-22 2007-04-19 Transcutaneous Technologies Inc. Iontophoresis device
US20090254018A1 (en) * 2005-08-24 2009-10-08 Mizuo Nakayama Electrode assembly for freezing-type iontophoresis device
JPWO2007026672A1 (ja) * 2005-08-29 2009-03-05 Ｔｔｉ・エルビュー株式会社 イオントフォレーシス用汎用性電解液組成物
WO2007029611A1 (ja) * 2005-09-06 2007-03-15 Tti Ellebeau, Inc. イオントフォレーシス装置
US20070112294A1 (en) * 2005-09-14 2007-05-17 Transcutaneous Technologies Inc. Iontophoresis device
KR20080047600A (ko) 2005-09-15 2008-05-29 티티아이 엘뷰 가부시키가이샤 로드형 이온토포레시스 장치
US20090216177A1 (en) * 2005-09-16 2009-08-27 Tti Ellebeau,Inc Catheter-type iontophoresis device
US20070073212A1 (en) * 2005-09-28 2007-03-29 Takehiko Matsumura Iontophoresis apparatus and method to deliver active agents to biological interfaces
JPWO2007037324A1 (ja) * 2005-09-28 2009-04-09 Ｔｔｉ・エルビュー株式会社 乾燥型イオントフォレーシス用電極構造体
US20090187134A1 (en) * 2005-09-30 2009-07-23 Hidero Akiyama Iontophoresis Device Controlling Amounts of a Sleep-Inducing Agent and a Stimulant to be Administered and Time at Which the Drugs are Administered
JP4902543B2 (ja) * 2005-09-30 2012-03-21 Ｔｔｉ・エルビュー株式会社 形状記憶セパレータを有するイオントフォレーシス用電極構造体およびそれを用いたイオントフォレーシス装置
WO2007038555A1 (en) * 2005-09-30 2007-04-05 Tti Ellebeau, Inc. Iontophoretic device and method of delivery of active agents to biological interface
WO2007041323A1 (en) * 2005-09-30 2007-04-12 Tti Ellebeau, Inc. Iontophoretic delivery of vesicle-encapsulated active agents
KR20080066712A (ko) * 2005-09-30 2008-07-16 티티아이 엘뷰 가부시키가이샤 관능화된 미세바늘 경피 약물 전달 시스템, 장치 및 방법
CA2664589A1 (en) * 2005-09-30 2007-04-12 Tti Ellebeau, Inc. Iontophoretic device and method of delivery of active agents to biological interface
US20070083186A1 (en) * 2005-09-30 2007-04-12 Darrick Carter Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles
US20070135754A1 (en) * 2005-09-30 2007-06-14 Hidero Akiyama Electrode assembly for iontophoresis for administering active agent enclosed in nanoparticle and iontophoresis device using the same
CN101277737A (zh) * 2005-09-30 2008-10-01 Tti优而美株式会社 将多种活性剂输送至生物界面的离子电渗装置
JP2009509656A (ja) * 2005-09-30 2009-03-12 Ｔｔｉ・エルビュー株式会社 生体界面に活性物質を送達するイオントフォレーシス装置における動作不良を検出するための方法及びシステム
US20070197955A1 (en) * 2005-10-12 2007-08-23 Transcutaneous Technologies Inc. Mucous membrane adhesion-type iontophoresis device
US20080033338A1 (en) * 2005-12-28 2008-02-07 Smith Gregory A Electroosmotic pump apparatus and method to deliver active agents to biological interfaces
US7848801B2 (en) * 2005-12-30 2010-12-07 Tti Ellebeau, Inc. Iontophoretic systems, devices, and methods of delivery of active agents to biological interface
EP1965858A2 (de) * 2005-12-30 2008-09-10 Tti Ellebeau, Inc. System und verfahren zur fernsteuerung eines iontophoresegerätes
WO2007080129A1 (en) 2006-01-13 2007-07-19 A Chan Holding B.V. Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction
DOP2007000015A (es) 2006-01-20 2007-08-31 Quark Biotech Inc Usos terapéuticos de inhibidores de rtp801
US20080039775A1 (en) * 2006-03-15 2008-02-14 Alza Corporation Apparatus and Method for Transdermal Delivery of Parathyroid Hormone Agents to Prevent or Treat Osteopenia
US20080004564A1 (en) * 2006-03-30 2008-01-03 Transcutaneous Technologies Inc. Controlled release membrane and methods of use
US20080004671A1 (en) * 2006-06-28 2008-01-03 Alza Corporation Vagus nerve stimulation via orally delivered apparatus
US20080009782A1 (en) * 2006-06-28 2008-01-10 Alza Corporation Methods and Devices for Transdermal Electrotransport Delivery of Lofentanil and Carfentanil
US20080114282A1 (en) * 2006-09-05 2008-05-15 Transcu Ltd. Transdermal drug delivery systems, devices, and methods using inductive power supplies
CA2661877A1 (en) 2006-09-05 2008-03-13 Tti Ellebeau, Inc. Non-destructive systems, devices, and methods for evaluating iontophoresis drug delivery devices
US7998745B2 (en) 2006-09-05 2011-08-16 Tti Ellebeau, Inc. Impedance systems, devices, and methods for evaluating iontophoretic properties of compounds
US20080260678A1 (en) * 2006-10-10 2008-10-23 University Of Colorado Molecular band-aid
JP2010507387A (ja) 2006-10-25 2010-03-11 クアーク・ファーマスーティカルス、インコーポレイテッド 新規のｓｉＲＮＡおよびその使用方法
EP2061551A2 (de) 2006-12-01 2009-05-27 TTI ellebeau, Inc. Systeme, vorrichtungen und verfahren zum antrieb oder zur steuerung von geräten, z. b. geräten zur transdermalen verabreichung
WO2008087884A1 (ja) 2007-01-16 2008-07-24 Tti Ellebeau, Inc. 薬物投与量の予測方法及びそのプログラム
US20080188791A1 (en) * 2007-02-02 2008-08-07 Difiore Attilio E Active iontophoresis delivery system
AU2008254748A1 (en) * 2007-05-18 2008-11-27 Tti Ellebeau, Inc. Transdermal delivery devices assuring an improved release of an active principle through a biological interface
US8197844B2 (en) * 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
WO2010008822A2 (en) 2008-06-23 2010-01-21 Adhezion Biomedical, Llc Cyanoacrylate tissue adhesives with desirable permeability and tensile strength
US8729121B2 (en) 2007-06-25 2014-05-20 Adhezion Biomedical, Llc Curing accelerator and method of making
CA2724949A1 (en) * 2007-06-27 2008-12-31 The General Hospital Corporation Method and apparatus for optical inhibition of photodynamic therapy
ES2474176T3 (es) 2007-06-27 2014-07-08 Quark Pharmaceuticals, Inc. Composiciones y métodos para inhibir la expresión de genes pro-apopt�ticos
RU2487716C2 (ru) 2007-10-03 2013-07-20 Кварк Фармасьютикалс, Инк. Новые структуры малых интерферирующих рнк (sirna)
US8613952B2 (en) 2007-11-14 2013-12-24 Adhezion Biomedical, Llc Cyanoacrylate tissue adhesives
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same
EP2106791A1 (de) 2008-03-31 2009-10-07 Biotempt B.V. Glutamin oder Glutamine enthaltendes Dipeptide in einer spezifischen Dosierung für die Behandlung von Entzündungen
CA2727015A1 (en) * 2008-06-04 2009-12-10 Coda Therapeutics, Inc. Treatment of pain with gap junction modulation compounds
US8198344B2 (en) 2008-06-20 2012-06-12 Adhezion Biomedical, Llc Method of preparing adhesive compositions for medical use: single additive as both the thickening agent and the accelerator
US8293838B2 (en) 2008-06-20 2012-10-23 Adhezion Biomedical, Llc Stable and sterile tissue adhesive composition with a controlled high viscosity
WO2010030738A2 (en) * 2008-09-10 2010-03-18 Transcu Ltd. Apparatus and method to dispense hpc-based viscous liquids into porous substrates, e.g., continuous web-based process
US9254133B2 (en) 2008-10-31 2016-02-09 Adhezion Biomedical, Llc Sterilized liquid compositions of cyanoacrylate monomer mixtures
US8609128B2 (en) 2008-10-31 2013-12-17 Adhezion Biomedical, Llc Cyanoacrylate-based liquid microbial sealant drape
US8652510B2 (en) 2008-10-31 2014-02-18 Adhezion Biomedical, Llc Sterilized liquid compositions of cyanoacrylate monomer mixtures
WO2010080452A2 (en) 2008-12-18 2010-07-15 Quark Pharmaceuticals, Inc. siRNA COMPOUNDS AND METHODS OF USE THEREOF
US8190252B2 (en) 2009-02-12 2012-05-29 Incube Labs, Llc Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
US8961492B2 (en) 2009-02-12 2015-02-24 Incube Labs, Llc System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
US9008765B2 (en) 2009-02-12 2015-04-14 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
CA2790324C (en) 2009-02-26 2022-06-14 Joseph Desimone Interventional drug delivery system and associated methods
US9149509B2 (en) 2009-03-26 2015-10-06 Henry Ford Health System Methods for improving neurological outcome after neural injury and neurodegenerative disease
US20110092881A1 (en) * 2009-05-08 2011-04-21 Isis Biopolymer Inc. Iontophoretic device with contact sensor
JP2012525943A (ja) * 2009-05-08 2012-10-25 アイシス バイオポリマー，インク． 改良された対電極を備えるイオントフォレシス装置
CN102458418B (zh) 2009-06-08 2015-09-16 夸克制药公司 一种寡核苷酸化合物的制药用途
EP2440694A4 (de) * 2009-06-09 2012-12-19 Tti Ellebeau Inc Langlebige elektrode von hoher kapazität und herstellungsverfahren dafür
US8903485B2 (en) 2009-08-06 2014-12-02 Incube Labs, Llc Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
AU2010324658A1 (en) 2009-11-26 2012-05-03 Quark Pharmaceuticals, Inc. siRNA compounds comprising terminal substitutions
US8685038B2 (en) 2009-12-07 2014-04-01 Incube Labs, Llc Iontophoretic apparatus and method for marking of the skin
AU2010328104B2 (en) 2009-12-09 2014-10-30 Nitto Denko Corporation Modulation of hsp47 expression
US8778904B2 (en) 2009-12-09 2014-07-15 Quark Pharmaceuticals, Inc. Methods and compositions for treating diseases, disorders or injury of the CNS
JP5463136B2 (ja) * 2009-12-22 2014-04-09 帝國製薬株式会社 イオントフォレーシス療法に用いる電極装置
WO2011084193A1 (en) 2010-01-07 2011-07-14 Quark Pharmaceuticals, Inc. Oligonucleotide compounds comprising non-nucleotide overhangs
US8986279B2 (en) 2010-02-10 2015-03-24 Incube Labs, Llc Methods and architecture for power optimization of iontophoretic transdermal drug delivery
JP2013520444A (ja) 2010-02-22 2013-06-06 ヘルス エンハンスメント プロダクツ インコーポレイテッド 高コレステロール血症を処置するための薬剤及び機序
DK2557924T3 (da) 2010-04-13 2019-09-23 Relmada Therapeutics Inc Dermale farmaceutiske sammensætninger af 1-methyl-2',6'-pipecoloxylidid og fremgangsmåde til deres anvendelse
US9309019B2 (en) 2010-05-21 2016-04-12 Adhezion Biomedical, Llc Low dose gamma sterilization of liquid adhesives
CA2801928C (en) 2010-06-24 2018-04-10 Quark Pharmaceuticals, Inc. Double stranded rna compounds to rhoa and use thereof
US20140134231A1 (en) 2010-10-11 2014-05-15 Sanford-Burnham Medical Research Institute Mir-211 expression and related pathways in human melanoma
EP2649181B1 (de) 2010-12-06 2016-04-27 Quark Pharmaceuticals, Inc. Doppelsträngige oligonukleotidverbindungen mit positionsmodifikationen
WO2012118910A2 (en) 2011-03-03 2012-09-07 Quark Pharmaceuticals, Inc. Compositions and methods for treating lung disease and injury
AU2012223366B2 (en) 2011-03-03 2017-02-23 Quark Pharmaceuticals, Inc. Oligonucleotide modulators of the toll-like receptor pathway
US9796979B2 (en) 2011-03-03 2017-10-24 Quark Pharmaceuticals Inc. Oligonucleotide modulators of the toll-like receptor pathway
EP3626304A1 (de) 2011-03-24 2020-03-25 Incube Labs, Llc System und verfahren zur zweiphasigen transdermalen iontophoretischen abgabe von therapiemitteln
US8781571B2 (en) 2011-03-31 2014-07-15 Incline Therapeutics, Inc. Switch validation circuit and method
US8428708B1 (en) 2012-05-21 2013-04-23 Incline Therapeutics, Inc. Self-test for analgesic product
US9731121B2 (en) 2011-03-31 2017-08-15 Incline Therapeutics, Inc. Switch validation circuit and method
US8428709B1 (en) 2012-06-11 2013-04-23 Incline Therapeutics, Inc. Current control for electrotransport drug delivery
WO2013003697A1 (en) 2011-06-30 2013-01-03 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
US20130090633A1 (en) * 2011-10-07 2013-04-11 University Of Southern California Osmotic patch pump
WO2013070821A1 (en) 2011-11-08 2013-05-16 Quark Pharmaceuticals, Inc. Methods and compositions for treating diseases, disorders or injury of the nervous system
SG11201403756PA (en) 2012-01-01 2014-11-27 Qbi Entpr Ltd Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
US20140364484A1 (en) 2012-01-12 2014-12-11 Quark Pharmaceuticals, Inc. Combination therapy for treating hearing and balance disorders
EP2804606B1 (de) 2012-01-19 2017-06-28 Hybrid Medical, LLC Topische therapeutische formulierungen
US9314571B1 (en) * 2012-02-10 2016-04-19 Mphase Technologies, Inc. Drug delivery system
CN104736709A (zh) 2012-03-27 2015-06-24 科达治疗公司 基于钙粘蛋白调节的组合物和治疗
EP2849774A4 (de) 2012-05-18 2015-11-25 Otago Innovation Ltd Kombinationsbehandlungen und zusammensetzungen zur wundheilung
CA2873098A1 (en) 2012-05-23 2013-11-28 Cellixbio Private Limited Compositions and methods for the treatment of multiple sclerosis
CN104603100A (zh) 2012-05-23 2015-05-06 塞利克斯比奥私人有限公司 用于治疗炎症性肠病的组合物和方法
US20130315891A1 (en) 2012-05-25 2013-11-28 Matthew Charles Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
HUE032613T2 (en) 2012-06-04 2017-10-30 Diamedica Therapeutics Inc Human tissue kallikrein 1 is glycosylated isoforms
PT2864360T (pt) 2012-06-25 2018-01-05 The Brigham And Women`S Hospital Inc Terapêuticas dirigidas ao alvo
US9611473B2 (en) 2012-09-12 2017-04-04 Quark Pharmaceuticals, Inc. Double-stranded nucleic acid compounds
ES2704855T3 (es) 2012-09-12 2019-03-20 Quark Pharmaceuticals Inc Moléculas de oligonucleótido de doble cadena para p53 y métodos de uso de las mismas
JP6364009B2 (ja) 2012-09-12 2018-07-25 クォーク ファーマシューティカルズ インコーポレーティッドＱｕａｒｋ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． Ｐ５３に対する二本鎖オリゴヌクレオチド分子、およびその使用方法
JP6154025B2 (ja) 2012-12-24 2017-06-28 ニューロガストルクス，インコーポレイテッド Ｇｉ管障害を治療するための方法
KR20160029731A (ko) 2013-03-12 2016-03-15 더 제너럴 하스피탈 코포레이션 변형된 뮐러관 억제 물질(mis) 단백질 및 질환 치료를 위한 그 용도
US10232028B2 (en) 2013-06-13 2019-03-19 Zivo Bioscience, Inc. Compounds and methods for affecting cytokines
WO2015020960A1 (en) 2013-08-09 2015-02-12 Novartis Ag Novel lncrna polynucleotides
CN105658274A (zh) * 2013-09-19 2016-06-08 皇家飞利浦有限公司 使用射频电流的皮肤用治疗装置
EP3079712B1 (de) 2013-12-11 2022-02-02 The General Hospital Corporation Verwendung von anti-müller-hormon (amh)-proteine zur kontrazeption und ovariellen reservekonservierung
US9421297B2 (en) 2014-04-02 2016-08-23 Adhezion Biomedical, Llc Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides
US9844554B2 (en) 2014-06-24 2017-12-19 Neurogastrx, Inc. Prodrugs of metopimazine
WO2016046835A1 (en) 2014-09-26 2016-03-31 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy and neurological disorders
WO2016051420A1 (en) 2014-09-29 2016-04-07 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
EP3212626B1 (de) 2014-10-27 2018-11-07 Cellix Bio Private Limited Drei-komponenten-salze des fumarsäuremonomethylesters mit piperazin und ethylendiamin zur behandlung von multipler sclerosis
WO2016067297A1 (en) 2014-10-27 2016-05-06 Cellix Bio Private Limited Salts of valproic acid with piperazine, ethylenediamine, lysine and/or eicosapentaenoic ecid (epa) amine derivatives for the treatment of epilepsy
WO2016088132A1 (en) 2014-12-01 2016-06-09 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
CN107873024A (zh) 2015-02-09 2018-04-03 塞尔利克斯生物私人有限公司 用于治疗粘膜炎的组合物和方法
PL3258948T3 (pl) 2015-02-16 2024-04-22 Zivo Bioscience, Inc. Kompozycje przeciwzapalne i immunomodulujące zawierające klebsormidium i ich zastosowania
FR3034017B1 (fr) * 2015-03-24 2018-11-02 Feeligreen Matrice polymerique adhesive pour iontophorese et dispositif pour l'iontophorese comprenant ladite matrice
EP3416501A4 (de) 2016-02-16 2019-11-20 Zivo Bioscience, Inc. Ernährungsunterstützung für tiere durch verabreichung eines aus algen gewonnenen nahrungsergänzungsmittels
WO2017143345A1 (en) 2016-02-19 2017-08-24 Zp Opco, Inc. Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines
KR20190039723A (ko) 2016-08-11 2019-04-15 셀릭스 바이오 프라이빗 리미티드 과민성 장 증후군의 치료용 조성물 및 방법
BR112019006904A2 (pt) 2016-10-04 2019-07-02 Cellix Bio Private Ltd composições e métodos para tratamento de xerostomia
RU2019119089A (ru) 2016-11-28 2020-12-21 Целликс Био Прайвет Лимитед Композиции и способы лечения грибковых инфекций
EP3554494A4 (de) 2016-12-19 2021-02-17 Cellixbio Private Limited Zusammensetzungen und verfahren zur behandlung von entzündungen
AU2018230478A1 (en) 2017-03-09 2019-09-12 Diamedica Inc. Dosage forms of tissue kallikrein 1
US11660264B2 (en) 2017-08-23 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
IL272776B2 (en) 2017-08-23 2024-06-01 Zosano Pharma Corp A method for rapidly obtaining therapeutic concentrations of zolmitriptan for the treatment of migraines and cluster headaches
CN115007233B (zh) 2017-10-18 2023-11-10 核蛋白有限公司 包括具有薄膜晶体管和电容感测的双基底的数字微流体设备
EP3651747A4 (de) 2017-11-17 2020-07-22 Cellix Bio Private Limited Zusammensetzungen und verfahren zur behandlung augenkrankheiten
IL274233B2 (en) 2017-11-17 2024-04-01 Cellix Bio Private Ltd Compounds, preparations and methods for the treatment of eye disorders and skin diseases
US11660265B2 (en) 2018-06-28 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
US11724024B2 (en) * 2018-07-24 2023-08-15 University Of Maryland, College Park Inverted battery devices, and systems and methods for use thereof
US11353759B2 (en) 2018-09-17 2022-06-07 Nuclera Nucleics Ltd. Backplanes with hexagonal and triangular electrodes
WO2020081478A1 (en) * 2018-10-15 2020-04-23 E Ink Corporation Digital microfluidic delivery device
BR112021013455A2 (pt) * 2019-01-09 2021-09-14 Twenty Twenty Therapeutics Llc Dispositivo de dispensação de agente terapêutico, e, sistema
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine
EP3922720A1 (de) 2020-06-09 2021-12-15 Universidad de Murcia Therapie zur verhinderung unerwünschter kardialer remodellierung nach einem akuten myokardinfarkt
AU2021413245A1 (en) * 2020-12-30 2023-07-06 Children's Healthcare Of Atlanta, Inc. Methods and devices for inducement of sweat for medical diagnostics
US20220265582A1 (en) 2021-02-24 2022-08-25 Universitätsspital Basel Effects of mescaline and of mescaline analogs (scalines) to assist psychotherapy
US11801256B2 (en) 2021-06-08 2023-10-31 Universitätsspital Basel Antidepressant-psilocybin co-treatment to assist psychotherapy

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US250878A (en) * 1881-12-13 brush
GB174605A (en) * 1921-01-27 1923-04-19 Edith Amy Cook Improvements in cow milkers
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4274420A (en) * 1975-11-25 1981-06-23 Lectec Corporation Monitoring and stimulation electrode
US4325367A (en) * 1977-06-13 1982-04-20 Robert Tapper Iontophoretic treatment apparatus
CA1153427A (en) * 1978-12-11 1983-09-06 Patrick T. Cahalan Tape electrode
US4406658A (en) * 1981-03-06 1983-09-27 Medtronic, Inc. Iontophoretic device with reversible polarity
JPS5810066A (ja) * 1981-07-10 1983-01-20 株式会社アドバンス イオントフオレ−ゼ用プラスタ−構造体
US4419092A (en) * 1981-11-06 1983-12-06 Motion Control, Inc. Iontophoretic electrode structure
US4457748A (en) * 1982-01-11 1984-07-03 Medtronic, Inc. Non-invasive diagnosis method
US4731926A (en) * 1985-02-19 1988-03-22 Drug Delivery Systems Inc. Method of manufacturing disposable and/or replenishable transdermal drug applicators
US4557723A (en) * 1983-08-18 1985-12-10 Drug Delivery Systems Inc. Applicator for the non-invasive transcutaneous delivery of medicament
US4622031A (en) * 1983-08-18 1986-11-11 Drug Delivery Systems Inc. Indicator for electrophoretic transcutaneous drug delivery device
US4708716A (en) * 1983-08-18 1987-11-24 Drug Delivery Systems Inc. Transdermal drug applicator
US4640689A (en) * 1983-08-18 1987-02-03 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US4904247A (en) * 1984-08-31 1990-02-27 Kendall Company Pressure-sensitive hydrophilic laminate structures for use in wound dressing, transdermal and topical drug delivery
US4747819A (en) * 1984-10-29 1988-05-31 Medtronic, Inc. Iontophoretic drug delivery
US4702732A (en) * 1984-12-24 1987-10-27 Trustees Of Boston University Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
US4673565A (en) * 1985-05-03 1987-06-16 E. I. Du Pont De Nemours And Company Pharmaceutical compositions containing hollow fine tubular drug delivery systems
GB8512358D0 (en) * 1985-05-16 1985-06-19 Euro Celtique Sa Transdermal delivery system
JPS6222662A (ja) * 1985-07-19 1987-01-30 林原　健 イオン導入電子治療器
US4722726A (en) * 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
DE3775830D1 (de) * 1986-06-13 1992-02-20 Alza Corp Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
JPS63102768A (ja) * 1986-10-20 1988-05-07 山之内製薬株式会社 イオントフオレ−シス用の新規プラスタ−構造体
US4731049A (en) * 1987-01-30 1988-03-15 Ionics, Incorporated Cell for electrically controlled transdermal drug delivery
US4940456A (en) * 1987-02-10 1990-07-10 Dan Sibalis Electrolytic transdermal delivery of proteins
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US4927408A (en) * 1988-10-03 1990-05-22 Alza Corporation Electrotransport transdermal system
US5169382A (en) * 1988-10-03 1992-12-08 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5006108A (en) * 1988-11-16 1991-04-09 Noven Pharmaceuticals, Inc. Apparatus for iontophoretic drug delivery
US5088977A (en) * 1988-12-21 1992-02-18 Drug Delivery Systems Inc. Electrical transdermal drug applicator with counteractor and method of drug delivery
US5023085A (en) * 1989-11-29 1991-06-11 Pfizer Inc. Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
US6382529B1 (en) * 2001-09-28 2002-05-07 Sheng-Li Wu Water sprayer

Also Published As

Publication number Publication date
KR960014099B1 (ko) 1996-10-14
EP0436658B1 (de) 2003-03-26
EP0436658A1 (de) 1991-07-17
CA1337300C (en) 1995-10-10
ATE235284T1 (de) 2003-04-15
NZ230772A (en) 1991-04-26
DK175827B1 (da) 2005-03-14
KR900701349A (ko) 1990-12-01
DE68929458T2 (de) 2004-03-11
DK175622B1 (da) 2004-12-27
AU658246B2 (en) 1995-04-06
DE68929458D1 (de) 2003-04-30
DK59491A (da) 1991-04-03
PT91890A (pt) 1990-04-30
NO318115B1 (no) 2005-02-07
JP2918262B2 (ja) 1999-07-12
JPH11216192A (ja) 1999-08-10
CA1336781C (en) 1995-08-22
DK59491D0 (da) 1991-04-03
EP0931564A1 (de) 1999-07-28
JPH04505861A (ja) 1992-10-15
AU627786B2 (en) 1992-09-03
DK200401287A (da) 2004-08-26
PT91890B (pt) 1995-08-09
US5080646A (en) 1992-01-14
ATE234130T1 (de) 2003-03-15
AU4425489A (en) 1990-05-01
AU2987692A (en) 1993-02-11
US5322502A (en) 1994-06-21
FI911589A0 (fi) 1991-04-02
DE68929456T2 (de) 2004-01-08
WO1990003825A1 (en) 1990-04-19
NO911186D0 (no) 1991-03-25
JP3638805B2 (ja) 2005-04-13
US5169383A (en) 1992-12-08
EP0931564B1 (de) 2003-03-12
WO1990003825A9 (en) 2011-08-25
DE68929456D1 (de) 2003-04-17
NO911186L (no) 1991-06-03

Similar Documents

Publication Publication Date Title
FI119869B (fi) Lääkkeen elektrokuljetusvapautukseen tarkoitettu kontrollimembraani
US5496266A (en) Device and method of iontophoretic drug delivery
EP0528789B1 (de) Verfahren und vorrichtung zur iontophoretischen abgabe von medikamenten
US5503632A (en) Electrotransport device having improved cathodic electrode assembly
EP0596036B1 (de) Transdermale abgabevorrichtung
US5618265A (en) Iontophoretic delivery device with single lamina electrode
AU658789B2 (en) Iontophoretic drug delivery electrode and method of hydrating the same
JP3784069B2 (ja) 電気的輸送薬剤分配を増進する組成物
PT97140B (pt) Dispositivo para a administracao de substancias activas farmaceuticas por electroforese ionica
JPH05507017A (ja) イオン導入送出装置
JP2801083B2 (ja) イオン導入による薬物投与デバイスと方法
KR0154970B1 (ko) 이온 영동 약물 전달 장치 및 방법
IE19990566A1 (en) Electrotransport drug delivery
IE83794B1 (en) Electrotransport drug delivery
CA2015597C (en) Device and method of iontophoretic drug delivery
IE68880B1 (en) Device and method of iontophoretic drug delivery

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119869

Country of ref document: FI